NCT03832348Completed
Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment
18-FDG Tumour Metabolism Changes in PDL1 Superior to 50% Stage III/IV Non Small Cell Lung Cancer During First Line Treatment With Pembrolizumab
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
The aim of this study is to describe the early dynamics of 18-FDG uptake in non smal cell lung cancer during first line treatment with pembrolizumab, and to evaluate whether or not they differ according to treatment response at 3 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 5 Feb 2019
- Start date
- 17 Jun 2019
- Primary completion date
- 3 Jun 2024
- Lead sponsor
- Centre Henri Becquerel
- Diseases
- Lung cancer
- NCT number
- NCT03832348
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 17 Jun 2019 to the primary completion date, 3 Jun 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- no treatment by pembrolizumab
- immunosuppressive treatment
- uncontrolled diabete
- Pregnancy or breast-feeding
- curatorship or guardianship
- not possibility to follow-up the procedures of the study due to geographic, social or psychic reasons
Who the study is looking for
- Non operable non small cell lung cancer
- Indication of treatment by Pembrolizumab
- PD-L1 status superior to 50 %
- Age more than 18 years
- At least one measurable target
- Written inform consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Henri Becquerel Coordinator of this site? Confirm its status | Rouen | France | Unknown status |
| CHU Coordinator of this site? Confirm its status | Rouen | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.